We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.71 | 0.73% | 98.44 | 2,433 | 14:15:56 |
From May 2021 to May 2024
By Joe Hoppe
Syncona Ltd. shares rose Wednesday after it said Novartis AG has agreed to acquire its portfolio company Gyroscope Therapeutics Holdings PLC for up to $1.5 billion.
Shares at 0954 GMT were up 17.0 pence, or 8.5% at 217.0 pence.
The London-listed life-sciences investment company said the deal is comprised of an upfront cash payment of $800 million and up to $700 million on the achievement of certain milestones.
Syncona said it expects upfront cash proceeds of up to 334 million pounds ($443.2 million) from the point of sale of the ocular gene therapy company, representing a GBP180 million uplift to its current holding value, and up to GBP255 million of potential further proceeds.
The company said that the upfront proceeds will further strengthen its capital pool and improve its ability to expand its portfolio and fund companies.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
December 22, 2021 05:30 ET (10:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
